Navigation Links
FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
Date:2/3/2009

label clinical studies of Cinryze for both acute treatment and routine prophylaxis against angioedema attacks.

The Phase 3 acute treatment study was a randomized, double blind, placebo controlled multi-center trial in 71 patients evaluating the safety and efficacy profile of Cinryze for treatment of HAE attacks. The primary efficacy measure in the pivotal Phase 3 acute treatment study was the time from initial treatment to the start of unequivocal relief of the defining symptom. Based on the primary efficacy variable, in the All Randomized (ITT) Dataset, the likelihood of a patient having the start of unequivocal relief of the defining symptom was 2.048 times greater in the Cinryze treatment group than in the placebo treatment group (p=0.048). The median time to the start of unequivocal relief of the defining symptom was shorter in subjects in the Cinryze treatment group (two hours) than in subjects in the placebo treatment group (greater than four hours).

In the open label study of Cinryze as treatment for acute attacks of HAE, no patients who had acute laryngeal edema attacks required hospitalization or intubation. Cinryze was generally well tolerated. There were no deaths or serious adverse reactions related to Cinryze administration, or discontinuations due to treatment-emergent adverse events. In the analysis of 447 acute attacks in 82 patients, open label Cinryze administration provided substantial relief of the defining symptom in 93.4 percent of the attacks within four hours of injection, with a median time to onset of relief of 30 minutes. There was no observed loss of effectiveness over multiple administrations of Cinryze for subsequent HAE attacks.

About Cinryze C1 Inhibitor (human)

Cinryze is a highly purified, pasteurized and nanofiltered plasma-derived C1 inhibitor product that has been approved by FDA for routine prophylaxis against angioedema attacks in adolescent and adult patie
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
2. Chinese SFDA Grants Immtech Fast Track Status
3. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
4. NTMir Announces Research Grants for Epidemiology and Household Water as Source of Infection
5. FDA Grants Approval to Extend U.S. Enrollment and Clinical Trial
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents
8. FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
9. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
10. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
11. FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Pa. , Feb. 27, 2015  In recognition ... ongoing commitment to the global bleeding disorders community, ... 2 million international units (IUs) of protein therapies to ... international not-for- profit organization which has worked to improve ... bleeding disorders. The donation supports the WFH,s Global Alliance ...
(Date:2/27/2015)... TEL-AVIV, Israel , February 27, 2015 ... Unternehmen baut sein bahnbrechendes Überwachungssystem für kongestive ... weiter aus -   ... Medical Technologies, die ein neuartiges Herzüberwachungssystem für ... gab heute bekannt, dass sie ein Finanzierungsvorhaben ...
(Date:2/27/2015)... YORK , Feb. 27, 2015 /PRNewswire/ ... are increasing in applications as their effectiveness ... firm Kalorama Information.  Kalorama Information says that ... is the most powerful tool in proteomic ... spec; MS) through its traditional techniques has ...
Breaking Medicine Technology:CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3
... A new study looking at in-person, electronic, telephonic, fax ... their medications concludes that pharmacists at a retail store ... patients to take medicine as prescribed. (Logo: ... of more than 40 years of studies published in ...
... 21, 2010 Takeda Pharmaceutical Company Limited ("Takeda") ... Takeda Pharmaceuticals North America, Inc. ("TPNA"), have completed ... against the companies in response to their Abbreviated ... HCl), ACTO plus met® (pioglitazone HCl and ...
Cached Medicine Technology:New Study Finds Pharmacists and Nurses are the Most Effective Health Care 'Voices' in Promoting Medication Adherence 2New Study Finds Pharmacists and Nurses are the Most Effective Health Care 'Voices' in Promoting Medication Adherence 3Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride) 2Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride) 3Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride) 4Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride) 5Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride) 6
(Date:2/28/2015)... Aliso Viejo, California (PRWEB) February 28, 2015 ... announced the release of a new overlay plugin for Final ... Pixel Film Studios. , “FCPX Overlay Chromatic gives users total ... X,” said Christina Austin, CEO of Pixel Film Studios. “FCPX ... while maintaining an easy to use interface.” , FCPX Overlay ...
(Date:2/28/2015)... Viejo, California (PRWEB) February 28, 2015 ... release of TransFold Volume 2. A fully customizable ... X. , “TransFold Volume 2 gives users total control ... said Christina Austin, CEO of Pixel Film Studios. “TransFold ... Pro X editor.” , TransFold Volume 2 from Pixel ...
(Date:2/28/2015)... 28, 2015 My Shiney Hiney® LLC., the ... team to Las Vegas, Nevada for the annual ASD Market ... of the leading consumer-goods tradeshows and My Shiney Hiney will ... event. My Shiney Hiney can be found at booth number ... for the at-home personal hygiene brush and cleansing system exclusively ...
(Date:2/27/2015)... MA (PRWEB) February 27, 2015 ... mobility management services, and one of the ... announced support for Bell Mobility within their CLEAN ... of services. Wireless Analytics’ newly developed Bell ... reporting for the Canadian wireless carrier’s business customers. ...
(Date:2/27/2015)... February 27, 2015 Just a little ... for those suffering from Sjögren’s Syndrome after a new ... researchers at the University of Buffalo and Immco Diagnostics, ... research was to develop a new diagnostic test ... presence of new autoantibodies. Researchers aimed to develop a ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 3Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2
... , TARRYTOWN, N.Y., Nov. 24 ... presentation at the 21st Annual Piper Jaffray Healthcare Conference on ... 4:00 p.m. Eastern Time. The session may be accessed ... Investor Relations page. An archived version of the presentation ...
... few fear cyberbullying, survey finds , TUESDAY, Nov. 24 ... say their children use the Internet without adult supervision, ... about online predators, a new survey has found. , ... Mott Children,s Hospital National Poll on Children,s Health, show ...
... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Sundia ... is proud to announce,that the company received the Red Herring ... top 100 private technology companies in the Asia Pacific,region. , ... 100 list every year for various,regions, such as North America, ...
... ... treatment—and suggests the need to re-examine reimbursement. , ... Alpharetta, GA (Vocus) November 24, 2009 -- The proposed ... consumers, insurers, legislators and policy makers all weighing in with their views on what ...
... ... to expand his reach and keep an ongoing dialogue with patients. Through Facebook, Twitter, and ... practice and seeks to answer any questions that patients may have. , ... Atlanta, GA (Vocus) November 24, 2009 -- A ...
... ... Sinusitis patients life is regularly impacted by acute ... Nasal nebulizer offers the convenience of treating all types of Sinusitis ... found 82.9% of patients treated with Sinus Dynamics™ nasal nebulized antibiotics ...
Cached Medicine News:Health News:Parents Worry About Their Kids' Safety on the Internet 2Health News:Sundia MediTech Receives Red Herring Asia Top 100 Award 2Health News:Jackson & Coker Industry Report Addresses Health Care Reform 2Health News:Jackson & Coker Industry Report Addresses Health Care Reform 3Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 2Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 3Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 2Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 3Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 4
... is an automated blood gas analysis system ... reduce the steps in the analytical process, ... errors. The 1st automatic system consists of ... and FLEXQ automatic sample handling system. With ...
... RAPID Reader - Portable RAPIDViewing Software., ... Given Diagnostic System, which can be installed on ... to open Patient RAPID Report (PRR) videos created ... to save them, at home or on the ...
... is a unique tool that ... commands to activate shortcut keys ... the need to perform manual ... can devote your full attention ...
... Application for POLYGRAM NET™ (PNET) works ... to record and analyze pressure and ... The PNET software and Polygraf ID ... as well as self-adhesive cutaneous and ...
Medicine Products: